Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders

American Journal of Geriatric Psychiatry

Volumn 12, Issue 6, 2004, Pages 631-638

  Scott, Tammy Maria ^a,b,e   Tucker, Katherine L ^c   Bhadelia, Afsan ^b   Benjamin, Batia ^b   Patz, Samuel ^b   Bhadelia, Rafeeque ^b   Liebson, Elizabeth ^a   Price, Lori Lyn ^d   Griffith, John ^d   Rosenberg, Irwin ^c   Folstein, Marshal F ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Radiology ^*  (United States)

^c TUFTS UNIVERSITY   (United States)

^d Biostatistics Research Center Tufts

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; UREA;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BIPOLAR DISORDER; BRAIN SIZE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GERIATRIC PATIENT; HIPPOCAMPUS; HUMAN; KIDNEY FUNCTION; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MULTIINFARCT DEMENTIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITION; NUTRITIONAL DEFICIENCY; REVIEW; UREA NITROGEN BLOOD LEVEL; WHITE MATTER; ARTICLE; BLOOD; BRAIN; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; MATHEMATICAL COMPUTING; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE; STATISTICS; TEMPORAL LOBE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYGDALA; BIPOLAR DISORDER; BRAIN; DEMENTIA, VASCULAR; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; FEMALE; FOLIC ACID; HIPPOCAMPUS; HOMOCYSTEINE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; REFERENCE VALUES; STATISTICS; TEMPORAL LOBE; VITAMIN B 12;

EID: 16644382970     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200411000-00009     Document Type: Review

References (61)

1. Butters N: The Wernicke-Korsakoff syndrome: a review of psychological, neuropathological, and etiological factors. Curr Alcohol 1981; 8:205-232
2. 12 deficiency? J Am Geriatir Soc 1988; 36:1105-1112
3. Mayer J: Tropical malnutrition, 3: pellagra and other syndromes of malnutritions. Postgrad Med 1966; 39:A127-A131
4. Allen WP: Folic acid in the prevention of birth defects. Curr Opin Pediatr 1996; 8:630-634
5. Posner BE, Smigelski CG, Krachenfels MM: Dietary characteristics and nutrient intake in an urban homebound population. J Am Diet Assoc 1987; 87:452-456
6. Stevens DA, Grivetti LE, McDonald RB: Nutrient intake of urban and rural elderly receiving home-delivered meals. J Am Diet Assoc 1992; 92:714-718
7. 12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J Gerontol A Biol Sci Med Sci 1997; 52:M76-M79
8. Lindenbauni J, Rosenberg IH, Wilson PW, et al: Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994; 60:2-11
9. 12 concentrations relate to intake source in the Framingham Offspring Study. Am J Clin Nutr 2000; 71:514-522
10. van Asselt DZ, de Groot LC, van Staveren WA, et al: Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr 1998; 68:328-334
11. Fletcher R, Fairfield K: Vitamins for chronic disease prevention in adults; clinical applications. JAMA 2002; 287:3127-3129
12. Fairfield K, Fletcher R: Vitamins for chronic disease prevention in adults; scientific review. JAMA 2002; 287:3116-3126
13. 12 and folate levels to cognitive test performance in subtypes of geriatric major depression. J Geriatr Psychiatry Neurol 1990; 3:98-105
14. Goodwin JS, Goodwin JM, Garry PJ: Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983; 249:2917-2921
15. 6, folate, and homocysteine to cognitive performance in The Normative Aging Study. Am J Clin Nutr 1996; 63:306-314
16. Tucker KL, Riggs KM, Spiro AI: Nutrient intake is associated with cognitive function: The Normative Aging Study (abstract). Gerontologist 1999; 39:149
17. Duthie S, Whaley L, Collins A, et al: Homocysteine, B-vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002; 75:908-913
18. McCaddon A, Hudson P, Davies G, et al: Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001; 12:309-313
19. Budge M, Johnston C, Hogevorst E, et al: Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann N Y Acad Sci 2000; 903:407-410
20. Selhub J: Homocysteine metabolism. Annu Rev Nutr 1999; 19:217-246
21. Selhub J, Jacques PF, Bostom AG, et al: Relationship between plasma homocysteine, vitamin status, and extracranial carotid-artery stenosis in the Framingham Study population. J Nutr 1996; 126(suppl4):1258S-1265S
22. Fassbender K, Mielke O, Bertsch T, et al: Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999; 353:1586-1587
23. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al: Homocysteine, silent brain infarcts, and white-matter lesions: The Rotterdam Scan Study. Ann Neurol 2002; 51:285-289
24. Matsui T, Arai H, Yuzuriha T, et al: Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke 2001; 32:1116-1119
25. DeCarli C, Maisog J, Murphy D, et al: Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr 1992; 16:274-284
26. Bryan R, Wells S, Miller T, et al: Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly: data from the Cardiovascular Health Study. Radiology 1997; 202:47-54
27. Lehericy S, Baulac M, Chiras J, et al: Amygdalo-hippocampal MR volume measurements in the early stages of Alzheimer disease. Am J Neuroradiol 1994; 15:929-937
28. Jack CJ, Petersen R, Xu Y, et al: Medial-temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997; 49:786-794
29. Jacques PF, Rosenberg IH, Rogers G, et al: Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999; 69:482-489
30. 12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin-nondeficient population. Biol Psychiatry 1990; 27:125-137
31. Ebly EM, Schaefer JP, Campbell NR, et al: Folate status, vascular disease, and cognition in elderly Canadians. Age Ageing 1998; 27:485-491
32. La Rue A, Koehler KM, Wayne SJ, et al: Nutritional status and cognitive functioning in a normally aging sample: a 6-year assessment. Am J Clin Nutr 1997; 65:20-29
33. Onega RM, Requejo AM, Andres P, et al: Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997; 66:803-809
34. 12, C, and folate concentrations in the New Mexico Elder Health Survey: correlations with cognitive and affective functions. J Am Coll Nutr 2000; 19:68-76
35. Snowdon DA, Tully CL, Smith CD, et al: Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study. Am J Clin Nutr 2000; 71:993-998
36. Yoo JH, Chung CS, Kang SS: Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 1998; 29:2478-2483
37. Parnetti L, Bottiglieri T, Lowenthal D: Role of homocysteine in age-related vascular and non-vascular diseases. Aging (Milano) 1997; 9:241-257
38. Selhub J, Jacques PF, Bostom AG, et al: Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332:286-291
39. Dardik R, Varon D, Tamarin I, et al: Homocysteine and oxidized low-density-Upoprotein-enhanced platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation. Thromb Haemost 2000; 83:338-344
40. Ubbink J: Homocysteine: an atherogenic and a thrombogenic factor? Nutr Rev 1995; 53:323-325
41. Bellamy MF, McDowell IF: Putative mechanisms for vascular damage by homocysteine. J Inherit Metab Dis 1997; 20:307-315
42. Chambers JC, McGregor A, Jean-Marie J, et al: Demonstration of rapid-onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 1999; 99:1156-1160
43. de Groot PG, Willems C, Boers GH, et al: Endothelial cell dysfunction in homocysteinuria. Eur J Clin Invest 1983; 13:405-410
44. Lentz SR: Homocysteine and vascular dysfunction. Life Sci 1997; 61:1205-1215
45. Beal MF, Kowall NW, Swartz KJ, et al: Homocysteic acid lesions in rat striatum spare somatostatin- neuropeptide Y (NADPH-diaphorase) neurons. Neurosci Lett 1990; 108:36-42
46. Beal MF, Swartz KJ, Finn SF, et al: Neurochemical characterization of excitotoxin lesions in the cerebral cortex. J Neurosci 1991; 11:147-158
47. Lipton SA, Kim WK, Choi YB, et al: Neurotoxicity associated with dual actions of homocysteine at the N- methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 1997; 94:5923-5928
48. Kruman II, Kumaravel TS, Lohani A, et al: Folie acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002; 22:1752-1762
49. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449-1455
50. Butcher KS, Cechetto DF: Autonomic responses of the insular cortex in hypertensive and normotensive rats. Am J Physiol 1995; 268(1, Pt 2):R214-R222
51. Fassbender K, Bertsch T, Mielke O, et al: Adhesion molecules in cerebrovascular diseases: evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 1999; 30:1647-1650
52. Hogevorst E, Mendes Ribeiro H, Molyneux A, et al: Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white-matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002; 59:787-793
53. Seshadri S, Beiser A, Selhub J, et al: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New Engl J Med 2002; 346:476-483
54. McCaddon A, Davies G, Hudson P, et al: Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998; 13:235-239
55. Selhub J, Jacques PF, Wilson PW, et al: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-2698
56. Bostom AG, Shemin D, Lapane KL, et al: High-dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 1996; 49:147-152
57. McCully KS: Homocysteinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: a key case revisited. Nutr Rev 1992; 50:7-12
58. Rosenberg IH, Miller JW: Nutritional factors in physical and cognitive functions of elderly people. Am J Clin Nutr 1992; 55:1237S-1243S
59. Alpert JE, Maurizio F: Nutrition and Depression: the Role of Folate. Medscape Mental Health 1997; 2(1)
60. Bailey LB, Gregory JF: Folate metabolism and requirements. J Nutr 1999; 129:779-782
61. Bottiglieri T, Crellin RF, Reynolds EH: Folate and neuropsychiatry, in Folate in Health and Disease. Edited by Bailey LB. New York, Marcel Dekker, 1995, pp 435-462